Table 3 Sensitivity of malignant primary bone tumor cell lines to mafosfamide, cisplatin and doxorubicin
Drugs | Mafosfamide | Cisplatin | Doxorubicin | |
---|---|---|---|---|
Tumor type | Cell line | IC50 (μM) | IC50 (μM) | IC50 (nM) |
Reference OS | SaOS2 | 22±3 | 7±0.9 | 119±78 |
HOS | 7±3 | 3±0.2 | 147±37 | |
Reference ES | SKES1 | 17±7 | 3±0.6 | 47±14 |
A673 | 36±19 | 3±0.6 | 150±36 | |
Reference CS | SW1353 | 20±7 | 5±0.7 | 140±44 |
CAL78 | 46±12 | 7±3 | 80±38 | |
OUMS27 | 31±6 | 6±2 | 2591±1851 | |
CS cell line | CH03 | 28±13 | 5±1 | 360±55 |
CH56 | 34±13 | 9±4 | 184±54 |